TITLE

MAGNESIUM SULFATE SAFELY PREVENTS ECLAMPSIA

PUB. DATE
September 2002
SOURCE
International Family Planning Perspectives;Sep2002, Vol. 28 Issue 3, p136
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the safety of magnesium sulphate to prevent eclampsia. Side effects; Need to prioritize the supply and use of magnesium sulfate.
ACCESSION #
7496958

 

Related Articles

  • Epsom salts can halve eclampsia.  // GP: General Practitioner;6/3/2002, p3 

    Reports a study on the capability of magnesium sulphate to reduce the risk of eclampsia development in women with pre-eclampsia in Great Britain.

  • Magnesium for Preeclampsia and Eclampsia. Roberts, James M. // New England Journal of Medicine;7/27/95, Vol. 333 Issue 4, p250 

    Editorial. Discusses the use of magnesium sulfate in the prevention of eclampsia and preeclampsia in hypertensive pregnant women. Criticisms of its use; Effectiveness as therapy; Comparison to phenytoin; Potential benefits for the neonate; Vasospasm in preeclampsia; Indication for therapy;...

  • Magnesium could save hundreds of women's lives worldwide. Eaton, Lynn // BMJ: British Medical Journal (International Edition);6/8/2002, Vol. 324 Issue 7350, p1351 

    Reports on the health benefits of magnesium sulphate injections for pregnant women. How the injections aid in preventing eclampsia; Minor side effects reported; Prior reliance of doctors on diazepam, phenytoin, lytic cocktail, and other anticonvulsant treatments to reduce the risk of seizure in...

  • The Magpie Trial follow up study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761].  // BMC Pregnancy & Childbirth;2004, Vol. 4, p5 

    Background: The Magpie Trial compared magnesium sulphate with placebo for women with pre-eclampsia. 10,141 women were recruited, 8804 before delivery. Overall, 9024 children were included in the analysis of outcome at discharge from hospital. Magnesium sulphate more than halved the risk of...

  • Mortalidade materna por eclâmpsia. Novo, Joe Luiz Vieira Garcia; Gianini, Reinaldo José // Revista Brasileira de Saude Materno Infantil;abr-jun2010, Vol. 10 Issue 2, p209 

    Objective: to assess the factors associated with maternal mortality resulting from eclampsia. Methods: a retrospective cohort study reviewing the medical records of deliveries carried out at the Sorocaba Hospital Compound (between January 1995 and December 2005). The variables included were:...

  • Prevention and management of severe pre-eclampsia/eclampsia in Afghanistan. Young Mi Kim; Ansari, Nasratullah; Kols, Adrienne; Tappis, Hannah; Currie, Sheena; Zainullah, Partamin; Bailey, Patricia; van Roosmalen, Jos; Stekelenburg, Jelle // BMC Pregnancy & Childbirth;2013, Vol. 13 Issue 1, p1 

    Background An evidence-based strategy exists to reduce maternal morbidity and mortality associated with severe pre-eclampsia/eclampsia (PE/E), but it may be difficult to implement in low-resource settings. This study examines whether facilities that provide emergency obstetric and newborn care...

  • Erratum to: Magnesium sulphate salts on monuments in Saxony (Germany): regional geological and environmental causes. Siedel, Heiner // Environmental Earth Sciences;Oct2013, Vol. 70 Issue 4, p1941 

    A correction to the article "Magnesium sulphate salts on monuments in Saxony (Germany): regional geological and environmental causes" that was published in the 2013 issue is presented.

  • Magnesium sulfate for eclampsia prevention: Quality of care evaluation in a tertiary centre in Québec, Canada. Girard, Pascale; Quirion, Alexandre; Bureau, Yves-André; Sauvé, Nadine // Obstetric Medicine (1753-495X);Jun2014, Vol. 7 Issue 2, p71 

    The article presents information on a study aimed at evaluating MgSO4 use in eclampsia cases since 2002 in severe and non-severe preeclampsia. The study found about 35% of preeclampsia severity misdiagnosis. The study implemented informative measures aimed at achieving complete compliance with...

  • Magnesium sulfate exposure and neonatal intensive care unit admission at term. Girsen, A I; Greenberg, M B; El-Sayed, Y Y; Lee, H; Carvalho, B; Lyell, D J // Journal of Perinatology;Mar2015, Vol. 35 Issue 3, p181 

    Objective:The aim of this study was to investigate the effect of maternal magnesium sulfate (MgSO4) exposure for eclampsia prophylaxis on neonatal intensive care unit (NICU) admission rates for term newborns.Study Design:A secondary analysis of the Maternal-Fetal Medicine Unit Network Cesarean...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics